Journal article
Prevalence of atrial fibrillation in patients taking TSH suppression therapy for management of thyroid cancer.
Abstract
BACKGROUND: Suppression of thyroid stimulating hormone (TSH) below the normal range with administration of L-thyroxine has been shown to improve survival in patients treated for thyroid cancer (TC). Although most TC patients require long-term TSH suppression therapy, the effect of this treatment on cardiac rhythm remains unknown. A cross-sectional study was conducted to determine the prevalence of atrial fibrillation (AF) in TC patients on TSH …
Authors
Abonowara A; Quraishi A; Sapp JL; Alqambar MH; Saric A; O’Connell CM; Rajaraman MM; Hart RD; Imran SA
Journal
Clinical & Investigative Medicine, Vol. 35, No. 3, pp. e152–e156
Publisher
University of Toronto Press
Publication Date
June 1, 2012
DOI
10.25011/cim.v35i3.16591
ISSN
0147-958X